RxDoctor Payments Data

Beverly Bridges

Family · Birmingham, ALNPI 1619275153

Payments from drug & device makers

$2,314in general payments, 2019–2025

Across 112 payments — averaging $20.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$520
  • AbbVie$432
  • Pfizer$236
  • Ironwood Pharmaceuticals, Inc$190
  • Novo Nordisk$178
  • AstraZeneca$159
  • plus $598 from 18 others

What the payments were for

  • Food & beverage$2,314100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,314 in reported general payments places this provider in the 75th percentile of 3,415 family providers in Alabama.

See all family providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide35$35,258
MounjaroTirzepatide24$25,021
JanuviaSitagliptin Phosphate13$7,042
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$2,774
Doxycycline Monohydrate203$2,332
Vilazodone Hcl17$1,333
Atorvastatin Calcium55$1,083
Losartan Potassium55$865
Methylprednisolone77$681
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst41$632
Albuterol Sulfate HfaAlbuterol Sulfate25$510
Metformin Hcl ErMetformin Hcl18$507
Potassium Chloride20$497
Diclofenac Sodium23$491
Oseltamivir Phosphate13$458

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$178$35,25835 claims
Lilly USA, LLCMounjaro$520$25,02124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,415 family providers in Alabama.

Other family in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →